Trends and characteristics of culture-confirmed Staphylococcus aureus infections in a large U.S. integrated health care organization

Journal of Clinical Microbiology

Volumn 50, Issue 6, 2012, Pages 1950-1957

  Ray, G Thomas ^a   Suaya, Jose A ^b   Baxter, Roger ^c  

^a DIVISION OF RESEARCH   (United States)

^b GLAXOSMITHKLINE   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METICILLIN; OXACILLIN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLOOD CULTURE; CAUCASIAN; COMMUNICABLE DISEASE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEALTH CARE ORGANIZATION; HISPANIC; HOSPITAL INFECTION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; RISK FACTOR; STAPHYLOCOCCUS INFECTION; TREND STUDY; UNITED STATES;

ADULT; AGE DISTRIBUTION; AGED; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; ETHNIC GROUPS; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; INCIDENCE; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; UNITED STATES;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 84862093351     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00134-12     Document Type: Article

References (41)

1. Adam HJ, et al. 2009. Community-associated methicillin-resistant Staphylococcus aureus: prevalence in skin and soft tissue infections at emergency departments in the Greater Toronto Area and associated risk factors. CJEM 11:439-446.
2. Baba T, et al. 2002. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359:1819-1827. (Pubitemid 34607058)
3. Boucher HW, Corey GR. 2008. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 46(Suppl. 5):S344-S349. (Pubitemid 351717321)
4. Charlebois ED, et al. 2002. Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin. Infect. Dis. 34:425-433. (Pubitemid 34112261)
5. Crum NF, et al. 2006. Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus. Am. J. Med. 119:943-951. (Pubitemid 44634301)
6. David MZ, Daum RS. 2010. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin. Microbiol. Rev. 23:616-687.
7. Davis SL, et al. 2007. Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection. J. Clin. Microbiol. 45:1705-1711. (Pubitemid 46933895)
8. Daxboeck F, Assadian O, Apfalter P, Koller W. 2004. Resistance rates of Staphylococcus aureus in relation to patient status and type of specimen. J. Antimicrob. Chemother. 54:163-167. (Pubitemid 39028984)
9. Diamantis ML, Ortega-Loayza AG, Morrell DS. 2011. Update on the characterization of Staphylococcus aureus skin infections in a pediatric dermatology tertiary health care outpatient facility: antibiotic susceptibility patterns and decreased methicillin resistance. J. Am. Acad. Dermatol. 64:440-441.
10. Dietrich DW, Auld DB, Mermel LA. 2004. Community-acquired methicillin- resistant Staphylococcus aureus in southern New England children. Pediatrics 113:e347-e352.
11. Farley JE. 2008. Epidemiology, clinical manifestations, and treatment options for skin and soft tissue infection caused by community-acquired methicillin-resistant Staphylococcus aureus. J. Am. Acad. Nurse Pract. 20:85-92.
12. Francis JS, et al. 2005. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin. Infect. Dis. 40:100-107. (Pubitemid 40053465)
13. Frazee BW, et al. 2005. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann. Emerg. Med. 45:311-320. (Pubitemid 40261163)
14. Fridkin SK, et al. 2005. Methicillin-resistant Staphylococcus aureus disease in three communities. N. Engl. J. Med. 352:1436-1444.
15. Gordon NP. 2012. Similarity of the adult Kaiser Permanente membership in Northern California to the insured and general population in Northern California: statistics from the 2007 California Health Interview Survey. Kaiser Permanente Division of Research, Oakland, CA. http://www.dor.kaiser.org/ external/chis-non-kp-2007/.
16. Hulten KG, et al. 2006. Three-year surveillance of community onset health care-associated Staphylococcus aureus infections in children. Pediatr. Infect. Dis. J. 25:349-353.
17. Jungk J, Como-Sabetti K, Stinchfield P, Ackerman P, Harriman K. 2007. Epidemiology of methicillin-resistant Staphylococcus aureus at a pediatric healthcare system, 1991-2003. Pediatr. Infect. Dis. J. 26:339-344. (Pubitemid 46596660)
18. Kallen AJ, et al. 2010. Health care-associated invasive MRSA infections, 2005-2008. JAMA 304:641-648.
19. King MD, et al. 2006. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann. Intern. Med. 144:309-317. (Pubitemid 46768185)
20. Klein E, Smith DL, Laxminarayan R. 2007. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg. Infect. Dis. 13:1840-1846. (Pubitemid 350248484)
21. Klevens RM, et al. 2006. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin. Infect. Dis. 42:389-391. (Pubitemid 43122317)
22. Klevens RM, et al. 2006. Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerg. Infect. Dis. 12:1991-1993. (Pubitemid 44904946)
23. Klevens RM, et al. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763-1771. (Pubitemid 47598444)
24. Laupland KB, Ross T, Gregson DB. 2008. Staphylococcus aureus blood-stream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. J. Infect. Dis. 198:336-343.
25. Liu C, et al. 2008. A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005. Clin. Infect. Dis. 46:1637-1646. (Pubitemid 351706759)
26. Lucero CA, et al. 2009. Evaluating the potential public health impact of a Staphylococcus aureus vaccine through use of population-based surveillance for invasive methicillin-resistant S. aureus disease in the United States. Vaccine 27:5061-5068.
27. Miller LG, Kaplan SL. 2009. Staphylococcus aureus: a community pathogen. Infect. Dis. Clin. North Am. 23:35-52.
28. Miller LG, et al. 2007. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation. Clin. Infect. Dis. 44:471-482. (Pubitemid 46233247)
29. Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG, Fritsche TR. 2007. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagn. Microbiol. Infect. Dis. 57:7-13. (Pubitemid 44908825)
30. Moran GJ, Amii RN, Abrahamian FM, Talan DA. 2005. Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerg. Infect. Dis. 11:928-930. (Pubitemid 40720855)
31. Moran GJ, et al. 2006. Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 355:666-674.
32. Morin CA, Hadler JL. 2001. Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. J. Infect. Dis. 184:1029-1034. (Pubitemid 32955120)
33. Naimi TS, et al. 2003. Comparison of community-and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290:2976-2984. (Pubitemid 37505530)
34. O'Hara FP, et al. 2008. A geographic variant of the Staphylococcus aureus Panton-Valentine leukocidin toxin and the origin of community-associated methicillin-resistant S. aureus USA300. J. Infect. Dis. 197:187-194. (Pubitemid 351263436)
35. Orscheln RC, et al. 2009. Contribution of genetically restricted, methicillin- susceptible strains to the ongoing epidemic of community-acquired Staphylococcus aureus infections. Clin. Infect. Dis. 49:536-542.
36. Petti CA, Sanders LL, Trivette SL, Briggs J, Sexton DJ. 2002. Postoperative bacteremia secondary to surgical site infection. Clin. Infect. Dis. 34:305-308. (Pubitemid 34062229)
37. Richards MJ, Edwards JR, Culver DH, Gaynes RP. 1999. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit. Care Med. 27:887-892. (Pubitemid 29266004)
38. Sattler CA, Mason EO, Jr, Kaplan SL. 2002. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr. Infect. Dis. J. 21:910-917.
39. Shannon KP, French GL. 2002. Validation of the NCCLS proposal to use results only from the first isolate of a species per patient in the calculation of susceptibility frequencies. J. Antimicrob. Chemother. 50:965-969. (Pubitemid 36032818)
40. Shorr AF. 2007. Epidemiology and economic impact of meticillin-resistant Staphylococcus aureus: review and analysis of the literature. Pharmacoeconomics 25:751-768. (Pubitemid 47481640)
41. Young DM, et al. 2004. An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients. Arch. Surg. 139:947-951.